Abstract
Metabolomics together with genomics and proteomics contribute towards a better understanding of biological processes including addiction through a modern integrative approach known as systems biology. The excessive economic and social cost of drug addiction necessitates better understanding of how these drugs function and how they elicit variable response in the human body. Numerous studies involving animals and humans indicate that in addition to environmental factors, various genetic and metabolomic factors working in various signaling and interacting pathways in the brain play critical roles in mechanisms underlying drug addiction. The availability of the complete genome sequences, emergence of latest high throughput technologies and the development of powerful bioinformatics tools and applications allow researcher to seek novel approaches to understand these mechanisms. Several important integrative approaches are discussed in this chapter, for example, construction of biological interaction network and pathways from microarray data and construction of transcription regulatory network including their use in solving drug addiction disorders.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Agrawal A, Lynskey MT (2006) The genetic epidemiology of cannabis use, abuse and dependence. Addiction 101(6):801–812
Baak JP, Janssen EA, Soreide K et al (2005) Genomics and proteomics – the way forward. Ann Oncol 16(Suppl 2):ii30–44
Bansal M, Belcastro V, Ambesi-Impiombato A et al (2007) How to infer gene networks from expression profiles. Mol Syst Biol 3:78
Bierut LJ, Dinwiddie SH, Begleiter H et al (1998) Familial transmission of substance dependence: alcohol, marijuana, cocaine, and habitual smoking: a report from the collaborative study on the genetics of alcoholism. Arch Gen Psychiatry 55(11): 982–988
Breiter HC, Gollub RL, Weisskoff RM et al (1997) Acute effects of cocaine on human brain activity and emotion. Neuron 19(3):591–611
Calvano SE, Xiao W, Richards DR et al (2005) A network-based analysis of systemic inflammation in humans. Nature 437(7061):1032–1037
CDC (2005) Targeting tobacco use: the nation’s leading cause of death. National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, Atlanta, GA
Chefer VI, Kieffer BL, Shippenberg TS (2004) Contrasting effects of mu opioid receptor and delta opioid receptor deletion upon the behavioral and neurochemical effects of cocaine. Neuroscience 127(2):497–503
Claudino WM, Quattrone A, Biganzoli L et al (2007) Metabolomics: available results, current research projects in breast cancer, and future applications. J Clin Oncol 25(19):2840–2846
Elkon R, Linhart C, Sharan R et al (2003) Genome-wide in silico identification of transcriptional regulators controlling the cell cycle in human cells. Genome Res 13(5):773–780
Feala JD, Coquin L, Paternostro G et al (2008) Integrating metabolomics and phenomics with systems models of cardiac hypoxia. Prog Biophys Mol Biol 96(1–3):209–225
Feltenstein MW, See RE (2008) The neurocircuitry of addiction: an overview. Br J Pharmacol 154(2):261–274
Fessele S, Maier H, Zischek C et al (2002) Regulatory context is a crucial part of gene function. Trends Genet 18(2):60–63
Flatscher-Bader T, van der Brug MP, Landis N et al (2006) Comparative gene expression in brain regions of human alcoholics. Genes Brain Behav 5(Suppl 1):78–84
Flatscher-Bader T, Zuvela N, Landis N et al (2008) Smoking and alcoholism target genes associated with plasticity and glutamate transmission in the human ventral tegmental area. Hum Mol Genet 17(1):38–51
Gardner TJ, Kosten TR (2007) Therapeutic options and challenges for substances of abuse. Dialogues Clin Neurosci 9(4):431–445
German JB, Hammock BD, Watkins SM (2005) Metabolomics: building on a century of biochemistry to guide human health. Metabolomics 1(1):3–9
Gilchrist M, Thorsson V, Li B et al (2006) Systems biology approaches identify ATF3 as a negative regulator of Toll-like receptor 4. Nature 441(7090):173–178
Gomase VS, Changbhale SS, Patil SA et al (2008) Metabolomics. Curr Drug Metab 9(1):89–98
Hamon M, Bourgoin S, Artaud F et al (1981) The respective roles of tryptophan uptake and tryptophan hydroxylase in the regulation of serotonin synthesis in the central nervous system. J Physiol (Paris) 77(2–3):269–279
Harwood HJ, Fountain D, Fountain G (1999) Economic cost of alcohol and drug abuse in the United States, 1992: a report. Addiction 94(5):631–635
Huang S (2004) Back to the biology in systems biology: what can we learn from biomolecular networks? Brief Funct Genomic Proteomic 2(4):279–297
Kanehisa M, Goto S, Hattori M et al (2006) From genomics to chemical genomics: new developments in KEGG. Nucleic Acids Res 34 (Database issue):D354–D357
Kendler KS, Jacobson KC, Prescott CA et al (2003) Specificity of genetic and environmental risk factors for use and abuse/dependence of cannabis, cocaine, hallucinogens, sedatives, stimulants, and opiates in male twins. Am J Psychiatry 160(4):687–695
Koob GF (2006) The neurobiology of addiction: a neuroadaptational view relevant for diagnosis. Addiction 101(Suppl 1):23–30
Koob GF, Roberts AJ, Schulteis G et al (1998) Neurocircuitry targets in ethanol reward and dependence. Alcohol Clin Exp Res 22(1):3–9
Kreek MJ (2001) Drug addictions. Molecular and cellular endpoints. Ann NY Acad Sci 937:27–49
Kreek MJ, Nielsen DA, LaForge KS (2004) Genes associated with addiction: alcoholism, opiate, and cocaine addiction. Neuromolecular Med 5(1): 85–108
Leshner AI (1997) Addiction is a brain disease, and it matters. Science 278(5335):45–47
Li CY, Mao X, Wei L (2008) Genes and (common) pathways underlying drug addiction. PLoS Comput Biol 4(1):e2
Loney KD, Uddin KR, Singh SM (2003) Strain-specific brain metallothionein II (MT-II) gene expression, its ethanol responsiveness, and association with ethanol preference in mice. Alcohol Clin Exp Res 27(3):388–395
Loney KD, Uddin RK, Singh SM (2006) Analysis of metallothionein brain gene expression in relation to ethanol preference in mice using cosegregation and gene knockouts. Alcohol Clin Exp Res 30(1):15–25
Maxwell JC, Rutkowski BA (2008) The prevalence of methamphetamine and amphetamine abuse in North America: a review of the indicators, 1992–2007. Drug Alcohol Rev 27(3):229–235
Mayfield RD, Harris RA, Schuckit MA (2008) Genetic factors influencing alcohol dependence. Br J Pharmacol 154(2):275–287
Minozzi S, Amato L, Davoli M et al (2008) Anticonvulsants for cocaine dependence. Cochrane Database Syst Rev (2):CD006754
Nicholson JK, Lindon JC, Holmes E (1999) ‘Metabonomics’: understanding the metabolic responses of living systems to pathophysiological stimuli via multivariate statistical analysis of biological NMR spectroscopic data. Xenobiotica 29(11):1181–1189
O’Brien CP (2003) Research advances in the understanding and treatment of addiction. Am J Addict 12(Suppl 2):S36–S47
Oscar-Berman M, Marinkovic K (2007) Alcohol: effects on neurobehavioral functions and the brain. Neuropsychol Rev 17(3):239–257
Oscar-Berman M, Shagrin B, Evert DL et al (1997) Impairments of brain and behavior: the neurological effects of alcohol. Alcohol Health Res World 21(1):65–75
Oswald LM, Wand GS (2004) Opioids and alcoholism. Physiol Behav 81(2):339–358
Parker AJ, Marshall EJ, Ball DM (2008) Diagnosis and management of alcohol use disorders. BMJ 336(7642):496–501
Ron D, Jurd R (2005) The “ups and downs” of signaling cascades in addiction. Sci STKE 2005(309):re14
Saito T, Guan F, Papolos DF et al (2001) Mutation analysis of SYNJ1: a possible candidate gene for chromosome 21q22-linked bipolar disorder. Mol Psychiatry 6(4):387–395
Schuckit MA, Li TK, Cloninger CR et al (1985) Genetics of alcoholism. Alcohol Clin Exp Res 9(6):475–492
Segal E, Friedman N, Kaminski N et al (2005) From signatures to models: understanding cancer using microarrays. Nat Genet 37(Suppl):S38–S45
Shi YH, Zhu SW, Mao XZ et al (2006) Transcriptome profiling, molecular biological, and physiological studies reveal a major role for ethylene in cotton fiber cell elongation. Plant Cell 18(3):651–664
Singh SM, Treadwell J, Kleiber ML et al (2007) Analysis of behavior using genetical genomics in mice as a model: from alcohol preferences to gene expression differences. Genome 50(10):877–897
Stein EA, Pankiewicz J, Harsch HH et al (1998) Nicotine-induced limbic cortical activation in the human brain: a functional MRI study. Am J Psychiatry 155(8):1009–1015
Sullivan LE, Fiellin DA (2008) Narrative review: buprenorphine for opioid-dependent patients in office practice. Ann Intern Med 148(9):662–670
Szumlinski KK, Dehoff MH, Kang SH et al (2004) Homer proteins regulate sensitivity to cocaine. Neuron 43(3):401–413
Tapper AR, McKinney SL, Nashmi R et al (2004) Nicotine activation of alpha4* receptors: sufficient for reward, tolerance, and sensitization. Science 306(5698):1029–1032
Tegner J, Bjorkegren J (2007) Perturbations to uncover gene networks. Trends Genet 23(1):34–41
Tomlins SA, Mehra R, Rhodes DR et al (2007) Integrative molecular concept modeling of prostate cancer progression. Nat Genet 39(1):41–51
Treadwell JA, Singh SM (2004) Microarray analysis of mouse brain gene expression following acute ethanol treatment. Neurochem Res 29(2):357–369
True WR, Xian H, Scherrer JF et al (1999) Common genetic vulnerability for nicotine and alcohol dependence in men. Arch Gen Psychiatry 56(7):655–661
Tsuang MT, Lyons MJ, Meyer JM et al (1998) Co-occurrence of abuse of different drugs in men: the role of drug-specific and shared vulnerabilities. Arch Gen Psychiatry 55(11):967–972
Tyers M, Mann M (2003) From genomics to proteomics. Nature 422(6928):193–197
Uddin RK, Singh SM (2006) cis-Regulatory sequences of the genes involved in apoptosis, cell growth, and proliferation may provide a target for some of the effects of acute ethanol exposure. Brain Res 1088(1):31–44
Uddin RK, Singh SM (2007) Ethanol-responsive genes: identification of transcription factors and their role in metabolomics. Pharmacogenomics J 7(1):38–47
Uddin RK, Treadwell JA, Singh SM (2005) Towards unraveling ethanol-specific neuro-metabolomics based on ethanol responsive genes in vivo. Neurochem Res 30(9):1179–1190
Verstreken P, Koh TW, Schulze KL et al (2003) Synaptojanin is recruited by endophilin to promote synaptic vesicle uncoating. Neuron 40(4):733–748
Volkow ND, Li TK (2005) Drugs and alcohol: treating and preventing abuse, addiction and their medical consequences. Pharmacol Ther 108(1):3–17
Yuferov V, Kroslak T, Laforge KS et al (2003) Differential gene expression in the rat caudate putamen after “binge” cocaine administration: advantage of triplicate microarray analysis. Synapse 48(4):157–169
Zhang D, Zhang L, Lou DW et al (2002) The dopamine D1 receptor is a critical mediator for cocaine-induced gene expression. J Neurochem 82(6):1453–1464
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2010 Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Uddin, R.K., Singh, S.M. (2010). Metabolomics in Drug Response and Addiction. In: Johnson, B. (eds) Addiction Medicine. Springer, New York, NY. https://doi.org/10.1007/978-1-4419-0338-9_12
Download citation
DOI: https://doi.org/10.1007/978-1-4419-0338-9_12
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4419-0337-2
Online ISBN: 978-1-4419-0338-9
eBook Packages: MedicineMedicine (R0)